These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20099517)

  • 1. Formulation and evaluation of a proniosome hydrocortisone gel in comparison with a commercial cream.
    Sankar V; Praveen C; Prasanth KG; Srinivas CR; Ruckmann K
    Pharmazie; 2009 Nov; 64(11):731-4. PubMed ID: 20099517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
    Alsarra IA
    J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
    Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
    Wen MM; Farid RM; Kassem AA
    J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
    Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
    Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.
    Manosroi A; Jantrawut P; Manosroi J
    Int J Pharm; 2008 Aug; 360(1-2):156-63. PubMed ID: 18539416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alkylpolyglucoside surfactant as a prospective pharmaceutical excipient for topical formulations: the influence of oil polarity on the colloidal structure and hydrocortisone in vitro/in vivo permeation.
    Savić S; Savić M; Tamburić S; Vuleta G; Vesić S; Müller-Goymann CC
    Eur J Pharm Sci; 2007 Apr; 30(5):441-50. PubMed ID: 17331708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
    Liu J; Hu W; Chen H; Ni Q; Xu H; Yang X
    Int J Pharm; 2007 Jan; 328(2):191-5. PubMed ID: 16978810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proniosomes as drug carriers.
    Sankar V; Ruckmani K; Durga S; Jailani S
    Pak J Pharm Sci; 2010 Jan; 23(1):103-7. PubMed ID: 20067875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro release and antiinflammatory activity of topical formulations of ketoprofen.
    Moretti MD; Gavini E; Peana AT
    Boll Chim Farm; 2000; 139(2):67-72. PubMed ID: 10920531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation.
    Thakur R; Anwer MK; Shams MS; Ali A; Khar RK; Shakeel F; Taha EI
    J Drug Target; 2009 Jul; 17(6):442-9. PubMed ID: 19527115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: creation of a drug supersaturated state.
    Barichello JM; Handa H; Kisyuku M; Shibata T; Ishida T; Kiwada H
    J Control Release; 2006 Sep; 115(1):94-102. PubMed ID: 16919352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
    Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
    Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro skin permeation of estradiol from various proniosome formulations.
    Fang JY; Yu SY; Wu PC; Huang YB; Tsai YH
    Int J Pharm; 2001 Mar; 215(1-2):91-9. PubMed ID: 11250095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and evaluation of proniosomes containing lornoxicam.
    Madan JR; Ghuge NP; Dua K
    Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Liberation of hydrocortisone acetate from different commercial formulations].
    Neubert RH; Pötzsch A
    Pharmazie; 2004 Jun; 59(6):472-4. PubMed ID: 15248463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vehicles based on a sugar surfactant: Colloidal structure and its impact on in vitro/in vivo hydrocortisone permeation.
    Savić SD; Savić MM; Vesić SA; Vuleta GM; Müller-Goymann CC
    Int J Pharm; 2006 Aug; 320(1-2):86-95. PubMed ID: 16730932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effects of cosurfactants.
    El Maghraby GM
    Int J Pharm; 2008 May; 355(1-2):285-92. PubMed ID: 18243604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.